Literature DB >> 19853315

A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique.

Sheng Zi Wang1, Ji Li, Curtis T Miyamoto, Fu Chen, Li Fen Zhou, Hai Yan Zhang, Gang Yang, Wei Fang Wang, Ming Guo, Xiao Chen Ni, Lei Wang.   

Abstract

PURPOSE: This study evaluates the difference in damage to middle ear function with CRT and IMRT techniques in the treatment of nasopharyngeal carcinoma (NPC). We explore the isthmus of the Eustachian tube (ET) as the key anatomic site for the prevention of radiation-induced otitis media with effusion. METHODS AND MATERIALS: Eighty-two patients with NPC were divided into two groups: 40 patients treated with CRT and 42 patients treated with IMRT. The difference between dosage over the middle ear cavity and the isthmus of the ET was evaluated in both CRT group and IMRT group. All patients underwent hearing tests including pure tone audiometry and impedance audiometry before and after RT.
RESULTS: The dosage difference to the middle ear cavity and isthmus between these two groups was statistically significant (p<0.05). The difference in hearing test results between these two groups was also statistically significant (p<0.05). If we limited the dose to the middle ear cavity under 34 Gy and the dose to the isthmus under 53 Gy with IMRT, we may decrease radiation-induced OME even with the larger 2.25 Gy fraction size.
CONCLUSIONS: IMRT may have better protected the middle ear function compared with the CRT technique, even with larger fraction sizes than for the conventional CRT technique.

Entities:  

Mesh:

Year:  2009        PMID: 19853315     DOI: 10.1016/j.radonc.2009.09.013

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma.

Authors:  Shuang Huang; Xiaosheng Wang; Chaosu Hu; Hongmei Ying
Journal:  Med Oncol       Date:  2013-09-03       Impact factor: 3.064

2.  SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy.

Authors:  J Gao; T-L Qian; C-Z Tao; Y-H Zhang; Y Zhou; J Yang; J He; R Wang; P-J Zhou
Journal:  Br J Radiol       Date:  2015-06-25       Impact factor: 3.039

3.  The value of circulating CYFRA21-1 expression in patients with nasopharyngeal carcinoma: a study of 529 subjects.

Authors:  Xin-Mao Song; Zhu-Jian Wang; Wen-Jun Cao; Fu Chen; Sheng-Zi Wang
Journal:  Int J Clin Oncol       Date:  2016-07-12       Impact factor: 3.402

4.  The effectiveness of myringotomy and ventilation tube insertion versus observation in post-radiation otitis media with effusion.

Authors:  Paninee Charusripan; Likhit Khattiyawittayakun
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-24       Impact factor: 2.503

5.  Adverse Events of Concurrent Radiotherapy and ALK Inhibitors for Brain Metastases of ALK-Rearranged Lung Adenocarcinoma.

Authors:  Takaaki Nakashima; Takeshi Nonoshita; Hidenari Hirata; Kouji Inoue; Akira Nagashima; Tadamasa Yoshitake; Kaori Asai; Yoshiyuki Shioyama
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

6.  Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.

Authors:  Chung-Feng Hwang; Fu-Min Fang; Ming-Ying Zhuo; Chao-Hui Yang; Li-Na Yang; Hui-Shan Hsieh
Journal:  Biomed Res Int       Date:  2015-08-16       Impact factor: 3.411

7.  Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma.

Authors:  Xinmao Song; Shengzi Wang; Ji Li; Li Yan; Fu Chen; Jie Wang
Journal:  Arch Med Sci       Date:  2019-07-17       Impact factor: 3.318

Review 8.  Emerging treatment options for nasopharyngeal carcinoma.

Authors:  Lu Zhang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Drug Des Devel Ther       Date:  2013-02-01       Impact factor: 4.162

9.  Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma.

Authors:  Ji-Jin Yao; Guan-Qun Zhou; Li Lin; Wang-Jian Zhang; Ying-Lin Peng; Lei Chen; Ling-Long Tang; Yan-Ping Mao; Jun Ma; Ying Sun
Journal:  Sci Rep       Date:  2015-09-01       Impact factor: 4.379

10.  The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.

Authors:  Ling-Long Tang; Yu-Pei Chen; Chuan-Ben Chen; Ming-Yuan Chen; Nian-Yong Chen; Xiao-Zhong Chen; Xiao-Jing Du; Wen-Feng Fang; Mei Feng; Jin Gao; Fei Han; Xia He; Chao-Su Hu; De-Sheng Hu; Guang-Yuan Hu; Hao Jiang; Wei Jiang; Feng Jin; Jin-Yi Lang; Jin-Gao Li; Shao-Jun Lin; Xu Liu; Qiu-Fang Liu; Lin Ma; Hai-Qiang Mai; Ji-Yong Qin; Liang-Fang Shen; Ying Sun; Pei-Guo Wang; Ren-Sheng Wang; Ruo-Zheng Wang; Xiao-Shen Wang; Ying Wang; Hui Wu; Yun-Fei Xia; Shao-Wen Xiao; Kun-Yu Yang; Jun-Lin Yi; Xiao-Dong Zhu; Jun Ma
Journal:  Cancer Commun (Lond)       Date:  2021-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.